Eisai
4523.T
#2184
Rank
S$10.98 B
Marketcap
S$38.93
Share price
0.11%
Change (1 day)
-0.76%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2023: S$0.68 Billion

According to Eisai's latest financial reports the company's current earnings are S$5.06 Billion. In 2023 the company made an earning of S$0.68 Billion, an increase over its 2022 earnings that were of -S$29.54 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2023

Annual earnings

Year Earnings Change
2023S$0.68 B-2404.04%
2022-S$29.54 Million-103.6%
2021S$0.82 B-39.81%
2020S$1.36 B7.44%
2019S$1.26 B17.22%
2018S$1.08 B86.16%
2017S$0.58 B-23.52%
2016S$0.76 B26.97%
2015S$0.59 B22.3%
2014S$0.48 B-46.07%
2013S$0.90 B-21.85%
2012S$1.16 B-20.59%
2011S$1.46 B-8.91%
2010S$1.60 B19.21%
2009S$1.34 B